KMID : 0614720150580010057
|
|
Journal of Korean Medical Association 2015 Volume.58 No. 1 p.57 ~ p.63
|
|
Pharmacologic treatment for inflammatory bowel disease
|
|
Lee Kwang-Jae
|
|
Abstract
|
|
|
Inflammatory bowel disease (IBD) is a rare condition characterized by chronic or relapsing immune activation and inflammation in the gastrointestinal tract. Crohn¡¯s disease and ulcerative colitis are the major forms of IBD. Although their etiology is not clear, these conditions are increasingly recognized in Korea. There is no curative treatment for Crohn¡¯s disease and ulcerative colitis. The primary goals of current therapy are to induce and maintain remission, which is closely associated with a patient¡¯s quality of life. Various drugs are used for diverse clinical presentations of IBD. International and Korean guidelines for the management of Crohn¡¯s disease and ulcerative colitis have been developed and published. This review describes pharmacologic treatment for Crohn¡¯s disease and ulcerative colitis primarily based on the recently published guidelines.
|
|
KEYWORD
|
|
Crohn disease, Inflammatory bowel diseases, Ulcerative colitis
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|